4-(Tris(4-methyl-1H-pyrazol-1-yl)methyl)aniline
Round 1
Reviewer 1 Report
Comments and Suggestions for AuthorsThe article presented me to review process shows a synthesis, spectral characteristics as well as DFT calculation study about synthesis of 4-(tris(4-methyl-1H-pyrazol-yl)methyl)aniline.
The manuscript is prepared carefully. The article contains many important aspects. Nevertheless, in my humble opinion it can be improved. Therefore, I recommend its acceptance after a minor revision. Below I am adding comments intended to improve the manuscript.
1. In the introduction, line 25-26 as well as 28, please provide specific examples of applications.
2. In my opinion, it will be better to follow the text by entering the numbering of compounds in Figure 2 (can also change the name to "Scheme") and adding the numbering in the text into the whole manuscript.
3. In section "2.1. Synthesis” and “3. Materials and methods” information on the reaction monitoring method (TLC, HPLc or other) should be provided.
4. Part "2.4. Computational Studies" requires calculation of the transition state for both presented reactions in order to determine which of these reactions is more favored.
5. Please justify the choice of the level of theory used in DFT calculations.
6. Please add full details of the analyzes in section "3. Materials and Methods" (solvents, techniques and forms of analysis, intert standard ect).
7. Consider expanding the analysis of HSQC and HMBC into main text.
Author Response
Please see attachment.
Author Response File: Author Response.pdf
Reviewer 2 Report
Comments and Suggestions for AuthorsThis paper deals with the synthesis and characterization of 4-(tris(4-methyl-1H-pyrazol-1- 215yl)methyl)aniline. Authors developed facile synthetic method and well explained its crystal structure. The synthesis of novel Tp ligands is garnering significant interest in the fields of catalysis and medicinal chemistry. Therefore, I recommend this paper to publish in Molbank as it is.
Author Response
We are glad that you enjoyed our manuscript.